Ladostigil

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameLadostigil
Drug Alias Name拉多替吉LadostigiloLadostigilumLadostigil tartrateLadostigil hemitartrate +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitorsMonoamine oxidase A inhibitors
TargetsMonoamine oxidase AMonoamine oxidase B
Therapy Area/IndicationsCognitive DysfunctionCognition DisordersMemory Disorders +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySerbiaAustriaGermany +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvraham Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionCognition DisordersMemory Disorders +[5] 

Other Information

ATC CodeN/A
Related LinksKEGG